TORONTO, Nov. 22, 2023 (GLOBE NEWSWIRE) — Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough ventures that transform human wellness, is pleased to report that its U.S. biosciences subsidiary Mikra Cellular Sciences Inc. (“Mikra”) has received the first shipment of Serenity, a natural supplement for supporting symptoms of anxiety, at its warehouse in California in time for sale on Black Friday, November 24. To order Serenity starting this Friday, customers should visit wearemikra.com and are encouraged to sign up for updates and promotional offers at https://bit.ly/serenity-sign-up.
In addition, Mikra wishes to bring attention to the recent article in The New York Times, After Antidepressants, a Loss of Sexuality1, documenting modern medicine’s evolving understanding of the potential side effects of selective serotonin reuptake inhibitors (SSRIs), the typical frontline treatment prescribed for patients suffering from anxiety:
“Doctors and patients have long known that antidepressants can cause sexual problems… Well over half of people taking the drugs report such side effects. Now, a small but vocal group of patients is speaking out about severe sexual problems that have endured even long after they stopped taking selective serotonin reuptake inhibitors… The drugs’ effects have been devastating, they said, leaving them unable to enjoy sex or sustain romantic relationships.”
“With so many young people grappling with symptoms of anxiety in our modern world, we felt there was an opportunity to introduce a natural, science driven alternative to those seeking relief,” explained Meni Morim, CEO of Lifeist. “Our in-depth analysis of the extensive clinical research on steam-extracted lavender oil2 compelled us to move forward to develop a natural supplement for anxiety relief and introduce Serenity to the market. In particular, we found the lack of habit-forming abuse potential very encouraging.”3
What sets Serenity apart from competing products is the consistent GCMS-verified dose4 of the active ingredient combined with the integration of Mikra’s proprietary polyterpene blend that provides an agreeable flavor and aftertaste, addressing a common complaint voiced by early adopters of competing lavender oil products of a “perfume-like” taste. With Lifeist’s expertise with fragrant and flavorful botanicals, Serenity is poised to become the best tasting lavender oil extract supplement on the market. Plus, Serenity ships with a full 30-day supply in every bottle, as compared to the typical 7- or 14-day supply sold in competing lavender-based products.
Mikra is pushing biosciences beyond the expected with the belief that it is possible to add more active, vigorous, enjoyable and valuable years to your life through protecting and maintaining your cellular health.
Lifeist is committed to bringing natural products backed by real science to current and future customers and looks forward to introducing new products in the first half of 2024.
About Lifeist Wellness Inc.
Sitting at the forefront of the post-pandemic wellness revolution, Lifeist leverages advancements in science and technology to build breakthrough companies that transform human wellness. Portfolio business units include: CannMart, which operates a B2B wholesale distribution business facilitating recreational cannabis sales to Canadian provincial government control boards including for CannMart Labs, a BHO extraction facility producing high margin cannabis 2.0 products; Australian Vapes, one of Australia’s largest online retailers of vaporizers and accessories; and Mikra, a biosciences and consumer wellness company developing and selling innovative therapies for cellular health. Information on Lifeist and its businesses can be accessed through the links below:
www.lifeist.com
https://cannmart.com
https://wearemikra.com
www.australianvaporizers.com.au
Contact:
Meni Morim
CEO
Lifeist Wellness Inc.
Ph: 647-362-0390
Email: ir@lifeist.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release.
Forward Looking Information
This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not historical in nature contain forward-looking information. Forward-looking information can be identified by words or phrases such as “may”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen.
The forward-looking information contained herein, including, without limitation, statements related to the expected date that Serenity will be available for sale and the anticipated benefits of using Serenity instead of antidepressants to treat anxiety are made as of the date of this news release and are based on assumptions management believed to be reasonable at the time such statements were made, including without limitation, that Mikra will be able to take orders for Serenity on Black Friday expectations relating to the effectiveness of lavender oil and its extracts in treating anxiety as demonstrated in published materials and studies, its expectation that the nutraceutical market will develop as currently anticipated, the nutraceutical market will continue to be a multi-billion dollar high-margin market, expectations that Serenity will gain market acceptance as a natural supplement alternative for the treatment of anxiety, along with the expansion of the market for nutraceutical products, as well as other considerations that are believed to be appropriate in the circumstances. While we consider these assumptions to be reasonable based on information currently available to management, there is no assurance that such expectations will prove to be correct. By its nature, forward-looking information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct, and that objectives, strategic goals and priorities will not be achieved. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information in this news release. Such factors include, without limitation: the failure to successfully make Serenity available for sale as anticipated and in a timely manner, the failure of Serenity, a natural supplement alternative, to demonstrate a notable effectiveness in treating general anxiety disorder or other anticipated health benefits, the inability of the Company to develop Mikra’s business as anticipated, unanticipated changes to current regulations that would adversely impact Mikra’s business, unforeseen developments that would delay Mikra’s ability to sell Serenity, the risk that the expected demand for nutraceutical products in general and those of Mikra in particular does not develop as anticipated and risks relating to the Company’s ability to execute its business strategy and the benefits realizable therefrom. Additional risk factors can also be found in the Company’s current MD&A filed under the Company’s SEDAR profile at www.sedarplus.ca. Readers are cautioned not to put undue reliance on forward-looking information. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable law. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.
Source: Lifeist Wellness Inc.
1 After Antidepressants, a Loss of Sexuality https://www.nytimes.com/2023/11/09/health/antidepressants-ssri-sexual-dysfunction.html
2 Efficacy and safety of lavender essential oil capsules among patients suffering from anxiety disorders: A network meta-analysis https://www.nature.com/articles/s41598-019-54529-9
3 No Abuse Potential of Lavender Oil Extract https://academic.oup.com/ijnp/article/24/3/171/6029371
4 GCMS-verified doses have been rigorously confirmed through Gas Chromatography-Mass Spectrometry analysis, and provide a high level of confidence in the accuracy and reliability of the specified dosage, making it a crucial aspect of quality control in industries where precise and consistent dosing is essential for safety and efficacy.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/9db007ac-4834-4374-9476-c5f05724590c
